Delivery Order SPE2DB22D2103-SPE2DB25FR9VQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,215.00 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Acyclovir 500 mg/10 mL vials. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with a completion date of June 20, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as one of the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Acyclovir 1,000 mg/20 mL vials valued at $1,031.45. This firm fixed-price delivery order, which represents no set-aside procurement, is scheduled for completion by August 5, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.36 to AmerisourceBergen Drug Corp for the supply of Acyclovir 1,000 mg/20 mL vials. This firm fixed-price, non-set-aside contract was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, and performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction supporting federal medical supply requirements for antiviral...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $110 to Amerisourcebergen Drug Corporation for 500 mg/10 ml vials of acyclovir. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania between September 11-12, 2023. No major subcontractors or set aside designations were indicated. The delivery order was issued against an existing DLA pharmaceuticals...
- This is a $1,787.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565664392 - Acyclovir 200 mg/5 ml suspension in 473 ml bottles. The contract has a completion date of September 4, 2024 and was awarded on September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This federal contract award, valued at $2,995.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of 4564529138 - Acyclovir 5% Ointment 15GM, with a completion date of May 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Valacyclovir HCL 1 gram tablets (90-count package). The contract, valued at $6,306.47, carries a firm fixed price and represents a non-set-aside competitive award. The product is to be delivered to the Conshohocken, PA location with an ultimate completion date of September 3, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,422.09 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Valacyclovir HCL 1 gram tablets (90-count units). This is a non-set-aside competitive award with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 1, 2025, for Valacyclovir HCL 1 Gram Tablet 90s. The contract is valued at $1,327.44 with a firm fixed price structure and an ultimate completion date of August 4, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to compete openly for federal medical procurement...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valacyclovir HCL 1 gram tablets (90-count units) with a contract value of $3,608.64. This delivery order, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9VQDelivery Order
The Defense Logistics Agency awarded a $3,573.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Acyclovir 5% Cream in 5-gram units. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The firm fixed-price delivery order structure and the competitive award demonstrate AmerisourceBergen Drug Corp's established capability to meet federal pharmaceutical procurement requirements through the DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/19/25 |